How On-Campus MOB Financing Works in Philadelphia
Philadelphia occupies a rare position in the national medical office market. The metro is home to a dense cluster of academic medical centers and integrated health systems, including Penn Medicine, Jefferson Health, Temple Health, and Main Line Health, each of which drives meaningful demand for on-campus and campus-adjacent medical office product. These institutions are not passive tenants. They are expanding clinical footprints, consolidating physician groups under health system employment, and signing long-term net leases on purpose-built facilities that function as extensions of the hospital campus itself. For lenders, this translates directly into underwriting clarity: health system credit, mission-critical location, and lease structures that are difficult to replicate in the general office market.
On-campus MOB financing in Philadelphia is concentrated in a handful of high-activity submarkets. University City is the most institutionally dense, anchored by Penn Medicine and the broader University of Pennsylvania Health System presence. Center City captures overflow clinical demand and specialty practice consolidation. In the suburbs, King of Prussia, Plymouth Meeting, Conshohocken, and Bala Cynwyd are active nodes where health system expansion into affluent catchment areas is driving both new development and acquisition activity. Cherry Hill and Langhorne serve as secondary markets with solid suburban MOB fundamentals, though lender enthusiasm there tends to be more selective based on tenant credit and lease term remaining.
What separates on-campus product from general medical office in this market is the combination of health system tenancy and physical integration with the hospital. Facilities co-located with Penn Medicine or Jefferson Health campuses carry a fundamentally different risk profile than a suburban MOB leased to independent physician groups. Occupancy in institutional-quality Philadelphia MOB has held in the high 80s to low 90s percent range, and the on-campus subset consistently outperforms. Lenders price this distinction aggressively, and the spread differential between an on-campus deal with an investment-grade health system anchor and a comparable off-campus asset is material at every point in the capital stack.
Lender Appetite and Capital Stack for Philadelphia On-Campus MOB
For stabilized on-campus MOB deals in Philadelphia with a health system anchor, life insurance companies are the most competitive lenders in the current environment. With the 10-year Treasury in the range of 4.3 percent entering 2026, life companies are pricing investment-grade anchored product at spreads of approximately 125 to 175 basis points over the 10-year, producing all-in fixed rates in the mid-to-upper 5 percent range for the strongest deals. These executions come with longer fixed terms, typically 10 years, full or near-full term interest-only options for institutional sponsors, and non-recourse structure. Life companies active in the Philadelphia market are competing directly for Class A on-campus assets tied to Penn Medicine or Jefferson Health, and deal velocity in this segment is meaningfully faster than general office capital markets would suggest.
CMBS is the next tier and remains active for deals at or above $10 million with investment-grade or near-investment-grade health system credit. Spreads for this execution run wider, generally 175 to 250 basis points over the 10-year, and prepayment structure comes with standard defeasance or yield maintenance provisions. LTV for life company execution typically runs 60 to 70 percent on on-campus product, with CMBS reaching 65 to 75 percent depending on DSCR and lease term remaining. Regional banks including TD Bank, Fulton Bank, and Customers Bank are quoting actively in the Philadelphia metro, particularly for well-leased off-campus and transitional product, but for true on-campus deals with long-term health system leases, bank execution is rarely the lead option given the rate and structure advantages offered by life companies. Bridge debt from funds is relevant for lease-up situations, value-add acquisitions, or predevelopment scenarios ahead of a permanent takeout, with pricing over SOFR reflecting the transitional nature of those deals.
Underwriting Criteria That Matter in Philadelphia
Lenders underwriting on-campus MOB in Philadelphia focus first on the tenant credit profile and lease structure. Health system guaranty, remaining lease term, and the degree to which the facility is operationally integrated with the hospital campus are the primary credit anchors. A 15-year NNN lease guaranteed by an investment-grade health system is treated entirely differently from a co-terminus multi-tenant deal with physician group tenants lacking system-level credit support. Lenders will stress rollover scenarios even on long-term leases, and they want to understand what the building is worth without the anchor tenant. On-campus location is the clearest answer to that question, because replacement tenancy from the same or a competing health system is a credible exit assumption.
Building specifications matter significantly in Philadelphia's institutional MOB market. Medical-grade HVAC, reinforced floor systems capable of supporting imaging equipment, hospital-level electrical capacity, and ADA compliance throughout are minimum standards for life company and CMBS consideration. Lenders will flag functional obsolescence in older product regardless of lease quality. In Philadelphia specifically, some of the suburban stock in older nodes presents this issue, and lenders are applying additional caution to assets that require capital investment to remain competitive as clinical facilities. Sponsors should be prepared for detailed property condition and environmental review, particularly on any asset with prior healthcare or laboratory use.
Typical Deal Profile and Timeline
The on-campus MOB deals closing in Philadelphia today generally fall in the $15 million to $75 million range for single-asset transactions, with larger portfolio and campus deals extending well above $100 million for institutional sellers transacting with healthcare REITs or large private equity platforms. Lenders expect sponsors to arrive with institutional-quality experience: demonstrated ownership or development of healthcare real estate, existing relationships with health system tenants, and a capital structure that supports a non-recourse permanent loan without outsized leverage. Opportunistic developers or sponsors without a healthcare real estate track record will face additional scrutiny regardless of asset quality.
A realistic timeline from signed LOI to closing for a stabilized on-campus deal with life company execution runs approximately 60 to 90 days, assuming clean title, a fully executed lease, and no material environmental issues. CMBS execution can run slightly shorter on rate lock but introduces conduit-specific documentation requirements that add closing complexity. Bridge loan execution for transitional deals can move in 45 to 60 days with a responsive debt fund, though sponsors should build in buffer for third-party report turnaround, which is consistently slower in Philadelphia than in markets with more appraisal capacity concentrated around healthcare assets.
Common Execution Pitfalls Specific to Philadelphia
The first pitfall is conflating health system presence with health system credit. Not every lease signed by a Jefferson Health or Penn Medicine affiliate carries system-level guaranty. Physician group leases, even with health system employment relationships, are frequently underwritten at a different credit tier than leases carrying an explicit guaranty from the parent health system entity. Sponsors who structure acquisition pricing around life company execution and arrive at lender with a physician-group-only lease often find the capital stack repricing meaningfully at the CMBS or bank tier.
The second pitfall is suburban asset obsolescence. Philadelphia's suburban MOB stock in markets like Cherry Hill and parts of Bala Cynwyd includes a meaningful volume of older product that has not been updated to current clinical standards. Lenders are flagging deferred capital expenditure on HVAC, electrical systems, and imaging infrastructure, and they are requiring reserves or pricing that reflects functional risk. Sponsors underwriting these deals to life company terms before completing a full property condition assessment are frequently surprised late in the process.
The third pitfall is lease co-terminosity at the portfolio level. Sponsors assembling multi-asset portfolios of Philadelphia on-campus MOBs sometimes encounter concentration risk when multiple leases expire within the same 12 to 24 month window. Life companies and CMBS conduits will haircut the portfolio LTV or require partial cash flow reserves when rollover concentration is high, even where the individual assets are strong.
The fourth pitfall is timeline misalignment with health system transaction cycles. Penn Medicine and Jefferson Health procurement and real estate approval processes operate on institutional timelines that do not conform to lender lock periods. Sponsors who execute a rate lock before health system lease execution or lease amendment approvals are finalized expose themselves to rate lock extension fees or expiration risk, which can be costly in a volatile rate environment.
If you are working on an on-campus medical office acquisition, recapitalization, or development in Philadelphia or elsewhere in the region, CLS CRE has the lender relationships and healthcare real estate capital markets experience to structure the right execution for your deal. Our team has worked across the full MOB capital stack, from life company permanent loans to bridge debt fund facilities, on assets ranging from single campus buildings to multi-state health system portfolios. Contact Trevor Damyan at CLS CRE to discuss your deal in detail and access our full on-campus MOB financing program guide.